(PharmaNewsWire.Com, August 20, 2020 ) The veterinary monitoring equipment market is projected to reach USD 570 million by 2025 from USD 326 million in 2019, at a CAGR of 9.8%. The growth of this market is primarily attributed to factors such as the increasing awareness regarding animal health, increasing focus on animal health among pet owners, growing prevalence of diseases among companion animals, growing companion animal population, rising demand for pet insurance, growing animal health expenditure, and the rising number of veterinary practitioners & income levels in developed economies. The need for continuous pet health evaluation & diagnosis and wearable monitoring devices are gaining recognition as opportunity areas in the market.
DRE Veterinary (US) is one of the leading manufacturers of veterinary monitoring equipment and operates in collaborations with numerous veterinary hospitals and clinics, both small and large. It holds a leading position in the veterinary monitoring equipment market. The strong presence of DRE in the market can be attributed to the company’s robust product portfolio. To strengthen its market position, the company focuses on enhancing and upgrading its product portfolio in the rapidly evolving veterinary equipment market. In recent years, the company has upgraded its lineup of professionally refurbished veterinary equipment, such as anesthesia machines to strengthen its market share in the US and across the globe. The company’s economically priced equipment is used in universities and veterinary institutions to provide hands-on training to medical students. In addition, the company provides new equipment and services to top veterinary facilities, organizations, and academic institutes, which helps in increasing its share in the veterinary monitoring equipment market.
Smiths Group (UK) is one of the leading players in the global veterinary monitoring equipment market. This is mainly attributed to its wide geographic presence with various distribution partners across the globe. The company primarily focuses on strengthening its extensive global sales network. Smiths offers various capnographs and oximeters, such as Handheld Capnograph and the Tabletop Pulse Oximeter V3304. Nearly three-quarters of its end-user customers are hospitals, with other end users comprising the alternate care market, such as home care, clinics, and other surgery centers and OEM relationships. The company also provides clinical support to its customers with information pertaining to clinical aspects of veterinary products, which helps the company increase its customer base. In addition, Smiths also offers clinical education for veterinary professionals, which helps increase the adoption of the company’s products among veterinary professionals. The company has a diversified revenue system, which helps it to sustain its position in the market. The major competitors of Smiths in the veterinary monitoring equipment market are DRE Veterinary (US), Digicare Biomedical Technology (US), Midmark Corporation (US), and Medtronic plc (Ireland).
Other prominent players in the global veterinary monitoring equipment market are Digicare Biomedical Technology (US), Midmark Corporation (US), Medtronic plc. (Ireland), Bionet America, Inc. (Korea), SonoScape Medical Corporation (China), Hallowell EMC (US), MinXray, Inc. (US), Hallmarq Veterinary Imaging Ltd. (UK), Esaote S.p.A (Italy), Agfa-Gevaert N.V. (Belgium), Nonin Medical, Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Covetrus, Inc. (US), Vetland Medical Sales & Services LLC (US), Masimo Corporation (US), Burtons Medical Equipment Ltd. (UK), Vetronic Services (UK), and IMV Technologies (France).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
